10x Genomics announced three clinically oriented collaborations—Dana‑Farber, the Cancer Research Institute and Brigham and Women’s Hospital—aimed at generating large single‑cell and spatial datasets tied to oncology and autoimmune disease outcomes. CEO Serge Saxonov also said the company plans to open a CLIA‑certified lab in early 2027 to support diagnostic and biomanufacturing customers. The partnerships will produce reference datasets to train AI models and benchmark spatial/transcriptomic biomarkers; 10x emphasized clinical translational use of Chromium and Xenium platforms and positioned diagnostics as a strategic growth area beyond research tools.